Our Role in Curbing this Devastation
The new course for 2021-2022 is now here!
2023-2024 Course Launching Soon!
The updated course for 2023-24 will launch by November 20, 2023. If you purchase the opioid course after November 1, you will be enrolled in the new course and notified when it launches.
This course satisfies the Utah Division of Occupational and Professional Licensing (DOPL) mandate which states that beginning with the licensing period that begins after January 1, 2014, as a condition precedent for license renewal, each controlled substance prescriber shall complete at least 3.5 continuing education hours per licensing period. The 3 hours of the core curriculum includes educational content covering the following:
- the scope of the controlled substance abuse problem in Utah and the nation,
- all elements of the FDA Blueprint for Prescriber Education under the FDA’s Extended-Release and Long-Acting Opioid Analgesics Risk Evaluation and Mitigation Strategy, as published July 9, 2012, or as it may be subsequently revised,
- the national and Utah-specific resources available to prescribers to assist in appropriate controlled substance and opioid prescribing,
- patient record documentation for controlled substance and opioid prescribing, and
- office policies, procedures, and implementation
Learners will need to pick at a minimum an additional half-hour of electives to satisfy the 3.5-hour requirement. Learners have the opportunity to earn a maximum of 8.00 hours of continuing education if all electives are taken.
This current course satisfies at least 3.5 hours of continuing education for controlled substance prescribers, except dentists who shall complete at least 2 hours to satisfy the DOPL requirements. This controlled substance prescribing class satisfies the division’s requirements for the continuing education required for the renewal of the controlled substance prescriber’s respective license type, is delivered by an accredited continuing education provider recognized by the division as offering continuing education appropriate for the controlled substance prescriber’s respective license type, and include a post-course knowledge assessment.
In addition, an M.D. or D.O. completing continuing professional education hours will complete those hours in classes that qualify for the American Medical Association Physician’s Recognition Award Category 1 credit. All others (non-M.D. or D.O.s) could also seek continuing education credits in accordance with your organizations’ requirements. We are also offering maintenance of certificate Part II credits for the following boards: American Board of Otolaryngology Head and Neck Surgery, American Board of Pathology, American Board of Internal Medicine, American Board of Pediatrics, and American Board of Anesthesiology. Please ensure you provide the necessary credentials upon registration to receive these credits.
Please note: A controlled substance prescriber who, on or after July 1, 2017, obtains a waiver to treat opioid dependency with narcotic medications, in accordance with the Drug Addiction Treatment Act of 2000, 21 U.S.C. Sec. 823 et seq., may use the waiver to satisfy the 3.5 hours of the continuing education requirement for two consecutive licensing periods. Therefore this course is not intended for those prescribers
Before proceeding with renewal, the following requirements must be met:
Physicians: Complete the required hours of CE as indicated in R156-67-304 (40 hours during each 2-year licensure cycle)
Controlled Substance: Complete the required hours of CE as indicated in 58-37-6.5 A minimum of 3.5 hours must be completed. The core 2.5-hour course consists of units 1-6, with an additional hour coming from at least one of the six elective courses.
Complete at least ONE of the online suicide prevention trainings on DOPL website (NEW for this cycle)
https://dopl.utah.gov/md/ – these qualify for CE credit:
- Suicide Prevention (0.5 credit)
- Supporting Patients (0.5 credit)
- Collaborative Safety Planning (0.5 credit)
- CALM-Utah (Counseling on Access to Lethal Means) (1 credit)
Upcoming: Beginning with the licensing period that begins after January 1, 2024, as a condition precedent for license renewal, each controlled substance prescriber shall complete at least 3.5 continuing education hours in an SBIRT-training class (currently available on our Substance Education Institute website)
- Certificate of Completion is provided for the number of hours you complete
- Core Curriculum: 3.00 Hours
- Electives: 5.00 Hours
- Max CE Available: 8.00 Hours
2021-2022 Current Concepts in Opioid Prescribing for the Adult and Pediatric Populations
Release Date: November 10, 2021
Expiration Date: December 31, 2023
Target Audience: Anyone in Utah licensed to prescribe opioids (physicians, APRNs, PAs, dentists, residents, and fellows)
Estimated Completion Time: 8.00 hours
Method of Participation: To receive a statement of credit, you must:
- Watch the videos in their entirety
- Complete quizzes at the conclusion of each presentation viewed
Max CE Hours Available: 8.00
Designed by University of Utah Faculty:
We thank the Utah Women & Newborns Quality Collaborative within the Utah Department of Health and March of Dimes for their generous donation to the implementation of this educational course.
Dentists, Doctors, First Responders, Medical Staff, Nurses, Social Workers
|Unit 1: Introduction
|Unit 2: Adverse Effects of Opioids
|Unit 3: Opioid Dependence
|Unit 4: Opioid Misuse
|Unit 5: Overdose
|Unit 6: Special Circumstances
|Non-Opioid Alternatives for Chronic Pain Management
|Pediatric Considerations for Opioid Prescribing
|Preventing Opioid Overdose Death: Naloxone Rescue Kits
|Maintenance Assisted Treatment (MAT) for Opioid Use Disorder
|Motivational Interviewing and Brief Negotiated Interview in Practice
|The Impact of the Opidemic on Pregnant Women
|Dealing with the Epidemic of Neonatal Opioid Withdrawal Syndrome
The instructional content has been designed to comply with the Utah licensing opioid education requirement.
The University Of Utah School Of Medicine is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
The University of Utah School of Medicine designates this enduring activity for a maximum of 8.00 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Speaker and Planning Committee Disclosure Summary:
The University of Utah School of Medicine Continuing Medical Education Office (UUCME) meets ACCME Standards for Integrity and Independence expectations regarding the identification and mitigation of relevant financial relationships with ACCME-defined ineligible companies. Everyone in control of content, including all speakers and planners, must disclose financial relationships in any amount within the past 24 months and any relevant financial relationships must be mitigated prior to the activity start.
Neither the speaker(s), planner(s), nor anyone in control of content for this enduring activity have any financial relationship with commercial products or services discussed today the exception of Marcela Smid, who is a PI/research grant from Gilead Science Inc, a consultant for Organon and Rhia Ventures and Scott Junkins, single session Advisory Board for Roche/Genentech. All relevant financial relationships have been mitigated.
MOC Part II
Need all Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to:
- 08.00 Medical Knowledge MOC points in the American Board of Internal Medicine’s (ABIM) Maintenance of Certification (MOC) program; and
- 08.00MOC points in the American Board of Pediatrics’ (ABP) Maintenance of Certification (MOC) program; and
- 08.00 MOC points in the American Board of Otolaryngology Head and Neck Surgery Continuing Certification Lifelong Learning and Self-Assessment (ABOHNS) Maintenance of Certification (MOC part II) and enables the participant to earn their required annual part II self‐ assessment credit in the American Board of Otolaryngology – Head and Neck Surgery’s Continuing Certification program (formerly known as MOC). ; and
- 08.00 MOC Points in the American Board of Pathology Lifelong Learning (ABPath) and enables the participant to earn up to 1.0 Lifelong Learning (CME) credit in the American Board of Pathology (ABPath) Continuing Certification program.; and
- 08.00 MOC Points in the American Board of Anesthesiology (ABA) Successful completion of this CME activity enables the participant to earn up to 8.00 MOCA 2.0® points in the American Board of Anesthesiology® Maintenance of Certification in Anesthesiology Program®. Maintenance of Certification in Anesthesiology Program® and MOCA® are registered certification marks of the American Board of Anesthesiology®. MOCA 2.0® is a trademark of the American Board of Anesthesiology®
- 08.00 ABS SAM Continuous Certification credit points: Successful completion of this CME activity, which includes participation in the evaluation component, enables the learner to earn credit toward the CME and/or Self-Assessment requirements of the American Board of Surgery’s Continuous Certification program. It is the CME activity provider’s responsibility to submit learner completion information to ACCME for the purpose of granting ABS credit.
It is the CME activity provider’s responsibility to submit participant completion information to ACCME for the purpose of granting ABIM, ABP, ABA, ABOHNS, ABS SAM CC and ABPath MOC Part II credits.
Are you purchasing for multiple learners?
The purchaser will only need to pay once for all the learners who desire to take the course. Once payment is received, the purchaser will be given a code to distribute to the intended learners who can then enter the code to begin the course. More information…
Only logged in customers who have purchased this product may leave a review.